´ëÇÑ°íÇ÷¾ÐÇÐȸ Á¦57ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷) : 2022-11-04±³À°ÀÏÀÚ : 2022-11-04
±³À°Àå¼Ò : ¼¿ï, ÄÜ·¡µåÈ£ÅÚ(¿©Àǵµ) ±×·£µåº¼·ë
±³À°ÁÖÁ¦ :
(¿ÀÇÁ¶óÀÎ) Á¦57ȸ Ãß°è±¹Á¦Çмú´ëȸ (1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : ¼Áö¿ø
¿¬¶ôó : 02-565-3350
À̸ÞÀÏ :
ksh@koreanhypertension.org ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ½Å°æ°ú, °¡Á¤ÀÇÇаú»ý¸®ÇÐ, ¾à¸®ÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 26 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í *»çÀüµî·Ï: Á¤È¸¿ø(6¸¸¿ø), Á¤È¸¿ø ¿Ü(8¸¸¿ø), Àü°øÀÇ ¹× ±âŸ(4¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)*ÇöÀåµî·Ï: Á¤È¸¿ø(8¸¸¿ø), Á¤È¸¿ø ¿Ü(10¸¸¿ø), Àü°øÀÇ ¹× ±âŸ(5¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç/Àü°øÀÇ(2¸¸¿ø), ´ëÇлý_´ëÇпø»ý Á¦¿Ü(º¸°Ç´ë/°£È£´ë/ÀÇ´ë)(¹«·á), 65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-04 Rooom A 09:45~10:00 The Association among Fat Distribution, Insulin Resistance, and Hypertension Risk À念¿ì(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 10:00~10:15 How to Eat Wisely Our Asian Diet for Living Healthy Long Life with Less Cardiovascular Risks (CVR) Yukio Yamori(Mukogawa Women)
±³À°½Ã°£ 11-04 Rooom A 10:15~10:30 Visceral Fat Reduction and Improvement in BP ±¸À¯Á¤(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 10:30~10:45 What is the Effective Treatment of Obesity in Patient with Hypertension ÃÖÁ¾ÇÑ(°Ç±¹ÀÇ´ë)
Åä·Ð 11-04 Rooom A 10:45~11:00 ÆгΠÅäÀÇ Á¤Çý¹®, Á¶µ¿Çõ, Çã¶õ, Yook-Chin Chia(°æÈñÀÇ´ë, ¿¬¼¼¿øÁÖÀÇ´ë, ÇѾçÀÇ´ë, Sunway University)
±³À°½Ã°£ 11-04 Rooom A 11:10~12:20 Young Investigator Award ÀÓ»óÇö, ½ÅÁøÈ£(°¡Å縯ÀÇ´ë, ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 12:30~12:50 Importance of 24h BP Control for reducing CVD Risk ; The role of Edarbi À̼÷Áø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 12:50~13:10 Intensive treatment strategy in Hypertension Á¤Çý¹®(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 13:35~13:50 Heterogeneity of Treatment Effect in Hypertension À¯½ÂÂù(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 13:50~14:05 Novel Technology for BP Measurement °½ÃÇõ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 14:05~14:20 Artificial intelligence in Hypertension Kazuomi Kario(Jichi Medical University School of Medicine)
±³À°½Ã°£ 11-04 Rooom A 14:20~14:35 Digital Therapeutics: BP Management in the Digital Era ½Åµ¿È£(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-04 Rooom A 14:35~14:50 ÆгΠÅäÀÇ ±è´ëÈñ, ¹ÚÁعü, À̼ö¿¬(¿ï»êÀÇ´ë, ÀÌÈÀÇ´ë, ¼¼Á¾º´¿ø)
±³À°½Ã°£ 11-04 Rooom A 15:00~15:15 Global Trends in Hypertension Prevalence and Progress in Treatment and Control Bin Zhou(Imperial College London)
±³À°½Ã°£ 11-04 Rooom A 15:15~15:30 Epidemiology of Hypertension in China Jiguang Wang(Shanghai Jiaotong University)
±³À°½Ã°£ 11-04 Rooom A 15:30~15:45 Trends of Hypertension Prevalence and Management in Japan Katsuyuki Miura(Shiga University of Medical Science)
±³À°½Ã°£ 11-04 Rooom A 15:45~16:00 Trends of Hypertension Prevalence and Management in Korea ÀÌÈ£±Ô(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-04 Rooom A 16:00~16:15 ÆгΠÅäÀÇ ÀÌÁÖ¹Ì, ÀÌÇõÈñ, Á¶¼Ò¹Ì(À»ÁöÀÇ´ë, ¿¬¼¼ÀÇ´ë, Cardiovascular Disease Initiative)
±³À°½Ã°£ 11-04 Rooom A 16:25~16:40 Pathophysiological Link between Blood Pressure and Dementia ¼»ó¿ø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 16:40~16:55 Impact of Blood Pressure on Cognitive Function Pedro Guimarães Cunha(University of Minho Guimaraes)
±³À°½Ã°£ 11-04 Rooom A 16:55~17:10 Recent Evidence of Blood Pressure Variability on Cognition ±è¿¹¸²(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom A 17:10~17:25 What is the Optimal Strategy to Maintain Cognitive Function for the Patients with Hypertension? ±èÈñÁø(¼º±Õ°üÀÇ´ë)
Åä·Ð 11-04 Rooom A 17:25~17:40 ÆгΠÅäÀÇ ±èÁø±Ç, ¼ÕÀϼ®, ÃÖ¼ºÈÆ, Ç㼺Çõ(¿¬¼¼ÀÇ´ë, °æÈñÀÇ´ë, ÇѸ²ÀÇ´ë, °æÈñÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 09:45~10:00 What is Prehypertension? Is It Simply a Precursor State of Hypertension? ÀÌÈñ¼±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 10:00~10:15 Do All Individuals with Prehypertension Have Similar Risks? ¹ÚÁø¼±(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 10:15~10:30 How Should We Manage Individuals with Prehypertension? The Role of Exercise Á¦¼¼¿µ(¼¿ï½Ã¸³´ë)
±³À°½Ã°£ 11-04 Rooom B 10:30~10:45 How Should We Manage Individuals with Prehypertension? The Role of Diet Control and Medical Treatment ±è°æÁø(ÀÌÈÀÇ´ë)
Åä·Ð 11-04 Rooom B 10:45~11:00 ÆгΠÅäÀÇ ¾ÈÀ¯¶õ, Á¤¹ÌÇâ, Á¤È¿Áö, ÃÖÀçÇõ(°¡Å縯ÀÇ´ë, °¡Å縯ÀÇ´ë, ¼¿ï´ëÇб³, ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 11:10~11:25 BP Variability in OSA ¹è´ëȯ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 11:25~11:40 BP Variability in Dementia Á¶Á¤¼±(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 11:40~11:55 BP & Heart Rate Variability in ESRD ±èÇü´ö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 11:55~12:10 Seasonal Variation in Blood Pressure and the Risk of Cardiovascular Diseases Takayoshi Ohkubo(Teikyo University School of Medicine)
Åä·Ð 11-04 Rooom B 12:10~12:20 ÆгΠÅäÀÇ À̸éÈñ, À̼ö¿¬(°¡Å縯ÀÇ´ë, ´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 12:30~13:10 Effective Strategy for the Treatment of Hypertension ±è¿ìÇö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 13:35~13:50 Sarcopenia and Sarcopenic Obesity ±èÇöÁø(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 13:50~14:05 Improvement of Sodium/Potassium Ratio by Intervention Studies and Cardiovascular Risks Mari Mori(Mukogawa Women¡¯s University)
±³À°½Ã°£ 11-04 Rooom B 14:05~14:20 Sarcopenia and Arterial Stiffness ¾ÈÈ¿¼®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 14:20~14:35 Sarcopenia and CAD/Stroke/Renal Disease ¼Û¿µ¸²(ÇѸ²ÀÇ´ë)
Åä·Ð 11-04 Rooom B 14:35~14:50 ÆгΠÅäÀÇ ¼¿ø¿ì, ¼Àçºó, À̹ÎÈ£, Á¶»óÈ£(ÇѸ²ÀÇ´ë, ¼¿ïÀÇ´ë, ¼øõÇâÀÇ´ë, ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 15:00~15:15 Prevalence of Adolescent Essential Hypertension and Tracking of Blood Pressure from Childhood to Adulthood ±è¼ºÇý(Â÷ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 15:15~15:30 Effect of Screening for Hypertension in Children and Adolescents on Adult Hypertension ¹Ú¼¼Áø(À»ÁöÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 15:30~15:45 Clinical Trials on Adolescent Essential Hypertension and Their Outcome ½ÅÀçÀÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 15:45~16:00 Pathophysiology of Obesity-Induced Hypertension in Adolescents Á¤¼¼¿ë(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-04 Rooom B 16:00~16:15 ÆгΠÅäÀÇ ±èÁöÈ«, ±èÇý¼ø, Çѹ̿µ(¿¬¼¼ÀÇ´ë, ÀÌÈÀÇ´ë, °æÈñÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 16:25~16:40 Nocturnal Hypertension and Heart Failure ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 16:40~16:55 Measures of Hemodynamic Burden on Incidence HF: Brachial versus Central ±èÁöÈñ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 16:55~17:10 Management of Hypotension in Patients with Heart Failure Á¶À翵(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom B 17:10~17:25 Clinical Importance of Urinary Sodium Excretion in Acute Heart Failure À§Áø(°¡ÃµÀÇ´ë)
Åä·Ð 11-04 Rooom B 17:25~17:40 ÆгΠÅäÀÇ °ø¹Î±Ô, ±è¹Î°ü, ±è¿ìÇö, ÇöÁØÈ£(¼øõÇâÀÇ´ë, ¿¬¼¼ÀÇ´ë, ÇѾçÀÇ´ë, ¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 09:45~10:05 New Biomarker for Vascular Inflammation: Hormonal Regulation of APE1/Ref-1 Àüº´È(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 10:05~10:25 Immunity and Salt-Sensitivity in Hypertension ±èÀΰâ(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 10:25~10:45 Potassium Intake, Blood Pressure Variability and Cardiovascular Outcomes in Chronic Kidney Disease ¼»óÇå(Àü³²ÀÇ´ë)
Åä·Ð 11-04 Rooom C 10:45~11:00 ÆгΠÅäÀÇ ¹èÀºÈñ, ÀÌ»óÈ£, Áø¼±¾Æ(Àü³²ÀÇ´ë, °æÈñÀÇ´ë, Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 11:10~11:25 Effect of perindopril as the initial first-line treatment for patients with hypertension ¹ÚÀçÇü(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 11:45~12:00 Achieving target blood pressure with triple-combination therapy, Dukarb Plus ¼ÕÀϼ®(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 12:00~12:15 Dulaglutide exerts beneficial effects of ASCVD with Type 2 diabetes ÀÌÇØ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 12:30~13:10 Combination therapy of antihypertensive drugs for CV protection ±è¿ø(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 13:35~13:50 Tactics for Early Diagnosis of Pulmonary Hypertension ¹ÚÀçÇü(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 13:50~14:05 Tactics for Medical Management of Pulmonary Hypertension ±è°æÈñ(¼¼Á¾º´¿ø)
±³À°½Ã°£ 11-04 Rooom C 14:05~14:20 Tactics for Invasive Management of Pulmonary Hypertension ÀÌ»óÀ±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 14:20~14:35 Tactics of Lung Transplantation for Pulmonary Hypertension ÀÌÁø±¸(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-04 Rooom C 14:35~14:50 ÆгΠÅäÀÇ ±è°èÈÆ, ³ª½Â¿ø, ³ªÁø¿À, ÀüÂùÈï(Àü³²ÀÇ´ë, ¿ï»êÀÇ´ë, °í·ÁÀÇ´ë, ¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 15:00~15:15 Challenges of Clinical Hypertension (CH) Á¤¿íÁø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 15:15~15:30 Tips and Supports from the Forerunner, KCJ äÀÎÈ£(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 15:30~15:45 Tips and Supports from the Forerunner, KJIM ÃÖ¹ü¼ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 15:45~16:00 For Better Tomorrow of Clinical Hypertension Çã¼±(ÇѸ²ÀÇ´ë)
Åä·Ð 11-04 Rooom C 16:00~16:15 ÆгΠÅäÀÇ ±èÁöÈñ, ¹ÚÀçÇü, Á¶ÇöÀç(°¡Å縯ÀÇ´ë, Ãæ³²ÀÇ´ë, ¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 16:25~16:50 °íÇ÷¾Ð ȯÀÚ¿¡¼ÀÇ ÁÖ¿ä ¾àÁ¦ ºÎÀÛ¿ë°ú ´ëó ¹æÇâ Á¶Àͼº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 16:50~17:15 °íÇ÷¾Ð ȯÀÚÀÇ °ü¸®Áß ÈçÈ÷ ¸¸³ª´Â Áú¹®°ú ´ëó ¹æÇâ ÀÌÇØ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom C 17:15~17:40 °íÇ÷¾Ð ȯÀÚ °ü¸® Update ¹ÚÂù¼®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 09:45~10:00 Pulsatile Hemodynamics and Coronary Artery Disease ±èÇзÉ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 10:00~10:15 Arterial Stiffness and Cerebral Small Vessel Disease ¹Ú±¤¿(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 10:15~10:30 Prognostic Value of Arterial Stiffness in Menopausal Women ±è¹Î°ü(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 10:30~10:45 The Role of Arterial Stiffness in CKD ±èÈ¿Áø(ºÎ»êÀÇ´ë)
Åä·Ð 11-04 Rooom D 10:45~11:00 ÆгΠÅäÀÇ ¹®Àαâ, ¹ÚÇö¿õ, ¾È°èÅÃ, ÀÌÁ¤È¯(¼øõÇâÀÇ´ë, Ãæ³²ÀÇ´ë, Ãæ³²ÀÇ´ë, ¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 11:10~11:35 Comprehensive CV risk management for hypertension patients with multiple risk factors ±è´ëÈñ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 11:50~12:20 Industrial Symposium IV ÁÖ½ÂÀç(Á¦ÁÖÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 12:30~12:50 °íÇ÷¾Ð ÇÕº´Áõ °ü¸®¿¡¼ ·Î»ç¸£ÅºÀÇ ¿ªÇÒ Á¶µ¿Çõ(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 12:50~13:10 The recent trend in managing dyslipidemia focused on intensive & combination therapy ±èº´±Ô(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 13:35~13:50 Pathophysiology of Preeclampsia Á¶ÀÎÁ¤(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 13:50~14:05 Long-Term Cardiovascular Disease Risk in Women after Hypertensive Disorders of Pregnancy ¼³»óÈÆ(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 14:05~14:20 Threshold and Target Blood Pressure for Drug Therapy in Hypertensive Disorders of Pregnancy ¾çµ¿Çå(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 14:20~14:35 Pulmonary Hypertension in Pregnancy ±èÇý¹Ì(Áß¾ÓÀÇ´ë)
Åä·Ð 11-04 Rooom D 14:35~14:50 ÆгΠÅäÀÇ ±èºÀÁØ, ÀÓ°æÈñ, Á¤Çý¹®(°í½ÅÀÇ´ë, µ¿¾ÆÀÇ´ë, °æÈñÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 15:00~15:15 OSA, is One of the Risk Factors or Comorbidities for Hypertension? ³ªÁø¿À(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 15:15~15:30 How about the Diurnal Pattern of Blood Pressure in Hypertensive Patients with OSA? ¹Ú»ó¹Î(À»ÁöÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 15:30~15:45 How to Treat the Hypertensive Patients with OSA: Combined CAPA and Antihypertensive Drug is Helpful? ÀÌÇØ¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 15:45~16:00 Dedicated OSA Treatment Can Improve the Clinical Outcomes in Hypertensive Patients with OSA? ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë)
Åä·Ð 11-04 Rooom D 16:00~16:15 ÆгΠÅäÀÇ ±è±¤½Ç, ±è¼ºÇØ, ±èÇзÉ, ÀÌÁÖÈñ(ÀÎÁ¦ÀÇ´ë, °Ç±¹ÀÇ´ë, ¼¿ïÀÇ´ë, ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 16:25~16:40 Beta Blocker for AF and HTN À̼ҷÉ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 16:40~16:55 Contribution of AF Burden for Future Heart Failure and Stroke Events ±èÁø¹è(°æÈñÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 16:55~17:10 Strategies of Rhythm Control in Elderly Patients with AF and HTN ½ÉÀç¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-04 Rooom D 17:10~17:25 Strategies of Anticoagulation in Elderly Patients with AF and HTN ¾çÇʼº(Â÷ÀÇ´ë)
Åä·Ð 11-04 Rooom D 17:25~17:40 ÆгΠÅäÀÇ ¹ÚÁعü, ¹ÚÁø±Ô, ÀÌ»óÀº, ÀÌÁ¤¸í(ÀÌÈÀÇ´ë, ÇѾçÀÇ´ë, ÀÌÈÀÇ´ë, °æÈñÀÇ´ë)